Fact CheckerSign in

NCT07694947Completed

Changes in Eosinophil Cationic Protein and Sputum Eosinophils Following Allergen Immunotherapy

Early Changes in Eosinophil Cationic Protein and Sputum Eosinophils Following Subcutaneous Allergen Immunotherapy in Allergic Asthma: A Prospective Cohort Study

Source: ClinicalTrials.gov · Last updated 18 Aug 2026

Brief summary (registry, in English)

Asthma is a chronic heterogeneous inflammatory airway disease affecting millions worldwide and remains a major global health burden. Despite advances in pharmacological therapy, a substantial proportion of patients continue to experience uncontrolled symptoms due to persistent airway inflammation and disease heterogeneity.

Status (registry)
Completed
Study type
Interventional
Enrollment
100 (actual)
First submitted
4 Jul 2026
Start date
Jan 2023
Primary completion date
Jul 2023
Lead sponsor
Mansoura University Hospital
Diseases
Asthma
NCT number
NCT07694947

What you commit to

  • Study type: Interventional
  • Participants enrolled: 100
  • From Jan 2023 to the primary completion date, Jul 2023
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • pregnant
  • parasitic infestations
  • recent acute asthma exacerbation
  • current smoking
  • severe persistent asthma

Who the study is looking for

  • Age above 18 years and diagnosed of allergic asthma. Patients were clinical stabile and confirmed diagnosis supported by pulmonary function test.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Mohamed AbdElmoniem
Coordinator of this site? Confirm its status
Al MansurahEgyptUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.